"We're sorry to every family we've let down," wrote CEO Robert Ford. The shuttered plant at the heart of the shortage will reopen in June, but it may take months before production is back to normal.

The Centers for Disease Control and Prevention's advice opens a third COVID-19 shot to healthy elementary-age kids — just like what is already recommended for everybody 12 and older.

But Abbott has said that, after production resumes, it could take about two months before new formula begins arriving in stores. The company's factory has been closed due to contamination problems.

The count of pediatric cases under investigation has grown since the agency's last update, but most of the increase represents previous cases that are just now being reported.

President Biden has invoked the Defense Production Act to try to help with the infant formula shortage. Suppliers must direct needed ingredients to formula manufacturers before filling other orders.

Just a handful of formula makers dominate the industry so a single plant shutdown can lead to empty shelves.

Biden is also authorizing the Defense Department to use commercial aircraft to fly formula supplies that meet federal standards from overseas to the U.S.

A new book argues that greater public support for parents is critical for the brain development of America's kids.

A new book argues that greater public support for parents is critical for the brain development of America's kids.

Abbott, one of the largest formula-makers in the U.S., has reached an agreement with the government to bring a closed factory back on line. And the FDA is easing some restrictions on imported formula.

After two years of isolation and uncertainty, many American teens are struggling with mental health problems. But they're also discovering themselves — and their own resilience.

States have been asked to increase accessibility of baby formula for recipients of the low-income program. And the Food and Drug Administration is looking at ways to make it easier to import formula.

The vaccine couldn't have come at a more critical time, with a surge in cases and deaths from malaria during the pandemic. But its efficacy — and its schedule — are far from ideal.

The vaccine couldn't have come at a more critical time, with a surge in cases and deaths from malaria during the pandemic. But its efficacy — and its schedule — are far from ideal.

The American Academy of Pediatrics is reexamining its treatment recommendations. Pediatricians have followed flawed guidelines linking race to risks for urinary infections and newborn jaundice.